Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation
Author(s) -
Douglas L. Packer,
Daniel B. Mark,
Richard A. Robb,
Kristi H. Monahan,
Tristram D. Bahnson,
Jeanne E. Poole,
Peter A. Noseworthy,
Yves Rosenberg,
Neal Jeffries,
L. Brent Mitchell,
Greg C. Flaker,
Evgeny Pokushalov,
Alexander Romanov,
T. Jared Bunch,
Georg Noelker,
Ardashev Av,
А. Ш. Ревишвили,
David J. Wilber,
Riccardo Cappato,
Karl-Heinz Kuck,
Gerhard Hindricks,
D. Wyn Davies,
Peter R. Kowey,
Gerald V. Naccarelli,
James A. Reiffel,
Jonathan P. Piccini,
A Silverstein,
Hussein R. AlKhalidi,
Kerry L. Lee
Publication year - 2019
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.0693
Subject(s) - medicine , atrial fibrillation , cardiology , catheter ablation , stroke (engine) , ablation , drug , pharmacotherapy , cardiac ablation , anesthesia , pharmacology , mechanical engineering , engineering
Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effects on long-term mortality and stroke risk are uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom